Case Report Describes Scurvy in Infant Consuming Almond Milk

Share this content:
Case Report Describes Scurvy in Infant Consuming Almond Milk
Case Report Describes Scurvy in Infant Consuming Almond Milk

TUESDAY, Jan. 19, 2016 (HealthDay News) -- The development of scurvy in an 11-month-old after exclusive intake of almond beverages and almond flour from age 2.5 months is described in a case report published online Jan. 18 in Pediatrics.

Isidro Vitoria, M.D., Ph.D., from the Hospital Universitario y Politécnico La Fe in Valencia, Spain, and colleagues report a case of scurvy after exclusive intake of almond beverages and almond flour from age 2.5 to 11.0 months of life. The 11-month-old infant had been tired and irritable for one month before examination and was referred for pathologic fractures of the femur and failure to thrive.

The authors note that the child had typical signs of scurvy, including osteopenia, cortical thinning, Wimberger ring, Frankel line, fracture, and periosteal reaction; he also had a very low plasmatic vitamin C level. Following diagnosis of scurvy he was treated with vitamin C replacement therapy (300 mg/day). The patient's general condition, pain in the legs, and radiologic features improved; plasmatic vitamin C level normalized; and he started walking over the following three months.

"In summary, this case demonstrates that scurvy is a new and severe complication of improper use of almond drinks in the first year of life," the authors write. "Manufacturers should indicate that these beverages are inappropriate for infants who consume a vitamin C-deficient diet."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths